leisure time -WSS

leisure time

author：focus 2025-08-24 04:06:36 - browse：7244

Rachel Haurwitz of Caribou Biosciences — Rachel Haurwitz, CEO of Caribou Biosciences. Elizabeth D. Herman for STAT

Caribou Biosciences said Thursday that its off-the-shelf CAR-T therapy induced durable, complete remissions in patients with advanced B-cell lymphoma that move it closer to the benchmarks set by more established, patient-specific CAR-T therapies.

In an update to an early-stage study, 44% of the 16 patients treated with Caribou’s on-demand therapy, called CB-010, achieved a complete remission lasting a minimum of six months — a key threshold of durability.

The CB-010 result is still preliminary, but it begins to compare favorably to currently approved CAR-T therapies, which must be custom made for each patient and have shown durable remission rates in the range of 36-40%, said Caribou CEO Rachel Haurwitz.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Physician executives need more than on

Wikipedia

WSS

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Medicare innovation center doesn’t save money, experts say

New oral drug delivery patch is modeled after octopus tentacles

Experts study whether long Covid risk adds up with each reinfection

Bill would stop addiction treatment from triggering child abuse inquiry

Chan Zuckerberg Biohub Chicago to focus on inflammation

focus

leisure time

leisure time

Supreme Court strikes down use of affirmative action

Phenylephrine and the overlooked value of the placebo effect

Sports medicine is finally prioritizing gender equality

What we owe ALS patients — and why one company fell short

Alkermes shareholders re

Bill would stop addiction treatment from triggering child abuse inquiry

Activists slam private health insurers over coverage restrictions

VC firm General Catalyst wants to buy a health system

Sports medicine is finally prioritizing gender equality

Study points to new risk in gene therapy death of Terry Horgan

hotspot

Chemotherapy drug shortage eases slightly but still widespread

Health insurers' Q3 question: how much care are people getting?

Senate panel eyes new effort on drug shortages

AI can decode, harness the power of the humane immune system

FDA authorizes Novavax’s updated Covid

2023 Nobel Prize in Medicine goes to Karikó and Weissman

knowledge

focus

Wikipedia

hotspot